India, Oct. 10 -- Responding to a World Health Organisation (WHO) query about the recent deaths of children allegedly due to a cough syrup, central drug regulator Central Drugs Standard Control Organisation (CDSCO) has informed it that three cough syrups - Coldrif, RespifreshTR and ReLife -have been recalled and manufacturers have been ordered to stop their production.
The CDSCO on Wednesday informed the global health agency that none of the products were exported from India, official sources said. The WHO had sought to know from Indian authorities whether the cough syrup linked to children deaths in the country was exported to other countries, they said. The WHO stated that it is closely monitoring recent media reports from India regardin...